MedPath

Comparison of the frequency of acute hemolysis induced nephropathy in patients with glucose 6 phosphate dehydrogenase deficiency treated with 3 different therapeutic fluid treatments

Not Applicable
Recruiting
Conditions
Glucose 6 Phosphate Dehydrogenase Deficiency.
Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
D55.0
Registration Number
IRCT20090111001545N5
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
132
Inclusion Criteria

age : 3 months - 18 years old
hemoglobinuria = 2+
intra venous fluid therapy for at least 24 hours
acute hemolysis induced Favism or glucose 6 phosphate dehydrogenase deficiency
hospitalization for 24 to 72 hours

Exclusion Criteria

Presence of Dysatremia
Central Diabetes insipidus or renal Diabetes insipidus
Barrett's Syndrome
Nephrotic Syndrome
Chronic Kidney Disease
Congestive heart failure
Liver cirrhosis
Metabolic diseases
Diabetic ketoacidosis
Congenital adrenal hypoplasia
shock
Glaucoma
Addison's disease
Unwiling to participate

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Frequency of Nephropathy due to Acute Hemolysis. Timepoint: Assessing the frequency of Nephropathy before intervention and 6, 12, 24, 48, and 72 hours after intervention. Method of measurement: Laboratory examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath